{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:25:43Z","timestamp":1789784743962,"version":"4.0.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jdcr.2023.05.022","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T21:22:38Z","timestamp":1685136158000},"page":"85-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Optic neuropathy in a patient treated with adalimumab for hidradenitis suppurativa"],"prefix":"10.1016","volume":"37","author":[{"given":"Sarah","family":"Alnaif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shambhawi","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Griffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Pariser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jdcr.2023.05.022_bib1","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of\u00a0adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jdcr.2023.05.022_bib2","article-title":"Ocular side effects of antirheumatic medications: a qualitative review","volume":"5","author":"Castillejo Becerra","year":"2020","journal-title":"BMJ Open Ophthalmol"},{"issue":"1","key":"10.1016\/j.jdcr.2023.05.022_bib3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/1203475415602840","article-title":"Clinical features and patient outcomes of hidradenitis suppurativa: a cross-sectional retrospective study","volume":"20","author":"Kim","year":"2016","journal-title":"J Cutan Med Surg"},{"issue":"2","key":"10.1016\/j.jdcr.2023.05.022_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2133.2011.10698.x","article-title":"Adalimumab (antitumour necrosis factor-\u03b1) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in\u00a0situ and ex\u00a0vivo study: adalimumab ameliorates inflammation\u00a0in HS","volume":"166","author":"van der Zee","year":"2012","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2023.05.022_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000447086","article-title":"Demyelinizing neurological disease after treatment with tumor necrosis factor-\u03b1 antagonists","volume":"7","author":"Bru\u00e8","year":"2016","journal-title":"Case Rep Ophthalmol"},{"issue":"8","key":"10.1016\/j.jdcr.2023.05.022_bib6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jamaneurol.2020.1162","article-title":"Association between tumor necrosis factor inhibitor exposure and inflammatory central nervous system events","volume":"77","author":"Kunchok","year":"2020","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.jdcr.2023.05.022_bib7","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/01658107.2014.925940","article-title":"Adalimumab and non-arteritic anterior ischaemic optic neuropathy: a case\u00a0report","volume":"38","author":"Kinard","year":"2014","journal-title":"Neuro-Ophthalmol"},{"issue":"4","key":"10.1016\/j.jdcr.2023.05.022_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000140257","article-title":"Anterior optic neuropathy associated with adalimumab","volume":"222","author":"von Jagow","year":"2008","journal-title":"Ophthalmologica"},{"issue":"6","key":"10.1016\/j.jdcr.2023.05.022_bib9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s40257-019-00455-5","article-title":"Ocular co-morbidities of atopic dermatitis. Part I: associated ocular diseases","volume":"20","author":"Beck","year":"2019","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2023.05.022_bib10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaad.2017.02.005","article-title":"Incidence of\u00a0hidradenitis suppurativa in the United States: a sex- and age-adjusted population analysis","volume":"77","author":"Garg","year":"2017","journal-title":"J Am Acad Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623001728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623001728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:25:10Z","timestamp":1762475110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512623001728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":10,"alternative-id":["S2352512623001728"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.05.022","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optic neuropathy in a patient treated with adalimumab for hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.05.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier, Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}